• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

AveXis - Articles and news items

spinal-muscular-atrophy

AveXis gains EU Orphan Drug designation for gene therapy treatment in spinal muscular atrophy

Industry news / 24 June 2015 / Victoria White

EMA grants Orphan Drug designation to AveXis’ gene transfer therapeutic currently in clinical development for the treatment of spinal muscular atrophy…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +